Werewolf Therapeutics (HOWL) Total Current Liabilities (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Total Current Liabilities of $7.9 million for Q2 2026, down 48.17% year-over-year from $15.2 million in Q2 2025, and down 79.59% on a QoQ basis from $38.5 million in Q1 2026.
Werewolf Therapeutics (HOWL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Total Current Liabilities for 7 years, with the latest figure at $7.9 million in Q2 2026.
- Total Current Liabilities for Q2 2026 came in at $7.9 million, down 48.17% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.9 million (down 48.17% YoY), and the FY2025 annual result was $36.1 million, up 138.13% from the prior year.
- Total Current Liabilities fell to $7.9 million in Q2 2026, from $38.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $38.5 million in Q1 2026 and troughed at $7.9 million in Q2 2026.
- A 5-year average of $19.5 million and a median of $16.4 million in 2024 frame the typical range for Total Current Liabilities.
- The widest annual swing landed in 2022, when Total Current Liabilities soared 312.05%; it then sank 50.59% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $24.0 million in 2022, then dropped by 19.22% to $19.4 million in 2023, then decreased by 21.66% to $15.2 million in 2024, then jumped by 138.13% to $36.1 million in 2025, then sank by 78.25% to $7.9 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $7.9 million in Q2 2026, $38.5 million in Q1 2026, and $36.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | 7.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.86 Mn |
| Mar 31, 2026 | 38.52 Mn |
| Dec 31, 2025 | 36.15 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 11.67 Mn |
| Dec 31, 2024 | 15.18 Mn |
| Sep 30, 2024 | 12.46 Mn |
| Jun 30, 2024 | 11.44 Mn |
| Mar 31, 2024 | 21.21 Mn |
| Dec 31, 2023 | 19.38 Mn |
| Sep 30, 2023 | 14.44 Mn |
| Jun 30, 2023 | 15.01 Mn |
| Mar 31, 2023 | 21.72 Mn |
| Dec 31, 2022 | 23.99 Mn |
| Sep 30, 2022 | 27.80 Mn |
| Jun 30, 2022 | 30.37 Mn |
| Mar 31, 2022 | 11.03 Mn |
| Dec 31, 2021 | 11.87 Mn |
| Sep 30, 2021 | 7.78 Mn |